3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1
Interventions
pembrolizumab
161
Nivolumab
133
Ipilimumab
78
Cyclophosphamide
47
Specimen Handling
44
Magnetic Resonance Spectroscopy
39
cemiplimab
35
Biopsy
31
fludarabine
29
trametinib
24
relatlimab
24
binimetinib
23
Interleukin-2
22
fludarabine phosphate
21
dabrafenib
20
atezolizumab
20
Radiotherapy
20
Opdualag
19
aldesleukin
18
Radiosurgery
18
CTLA-4 Antigen
18
encorafenib
17
Blood Specimen Collection
17
avelumab
14
Immunoglobulin G
14
Disulfides
13
lifileucel
11
lenvatinib
11
Bevacizumab
11
Paclitaxel
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tumor Necrosis Factor-alpha
×
Dermatologic
×
1 year
×
Clear all
NCT05222932
2025-08-07
AVENTIL
TILT Biotherapeutics Ltd.
Phase 1
Active not recruiting
15 enrolled